Illumina Inc (ILMN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ILMN | BMY | AMGN | GILD | REGN |
| Company | Illumina Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 134.92 | 49.89 | 337.03 | 84.39 | 1,149.66 |
| High | 136.19 | 50.04 | 338.50 | 84.65 | 1,154.79 |
| Low | 133.88 | 49.14 | 334.61 | 83.57 | 1,148.13 |
| Last | 135.62 | 49.15 | 338.00 | 83.76 | 1,160.40 |
| Change | +4.65 | -0.59 | +5.08 | -0.13 | +21.59 |
| % Change | +3.55% | -1.19% | +1.53% | -0.15% | +1.90% |
| Volume | 164,400 | 1,224,269 | 244,897 | 1,065,491 | 174,280 |
| 20-Day Average Volume | 1,298,962 | 8,210,736 | 1,688,932 | 6,292,804 | 398,483 |
| Previous Close | 130.97 | 49.74 | 332.92 | 83.89 | 1,138.81 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 129.20 | 49.10 | 329.68 | 80.08 | 1,165.58 |
| 20-Day Raw Stochastic | 89.41% | 61.97% | 94.35% | 92.24% | 39.17% |
| 20-Day Relative Strength | 60.62% | 55.36% | 59.06% | 72.35% | 53.21% |
| Weighted Alpha | +8.61 | -10.55 | +28.10 | +18.72 | +41.37 |
| Today's Opinion | 72% Buy | 72% Buy | 96% Buy | 88% Buy | 80% Buy |
| Previous Opinion | 64% Buy | 72% Buy | 88% Buy | 88% Buy | 80% Buy |
| Last Month's Opinion | 40% Buy | 40% Buy | 88% Buy | 56% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.55% since 09/12/24 | +2.16% since 09/12/24 | +2.37% since 09/12/24 | +1.19% since 09/12/24 | -1.10% since 09/12/24 |
| Low | 126.31 on 09/13/24 | 48.20 on 09/13/24 | 327.15 on 09/13/24 | 81.57 on 09/13/24 | 1,134.59 on 09/17/24 |
| High | 136.18 on 09/19/24 | 50.41 on 09/17/24 | 339.00 on 09/18/24 | 84.61 on 09/19/24 | 1,170.58 on 09/13/24 |
| 1-Month | |||||
| %Chg | -1.02% since 08/19/24 | -0.04% since 08/19/24 | +3.02% since 08/19/24 | +13.03% since 08/19/24 | -3.78% since 08/19/24 |
| Low | 120.51 on 09/12/24 | 46.88 on 08/22/24 | 319.00 on 09/06/24 | 74.34 on 08/20/24 | 1,113.24 on 09/11/24 |
| High | 137.18 on 08/20/24 | 50.75 on 09/04/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 1,211.20 on 08/27/24 |
| 3-Month | |||||
| %Chg | +24.44% since 06/18/24 | +20.75% since 06/18/24 | +10.42% since 06/18/24 | +33.25% since 06/18/24 | +10.83% since 06/18/24 |
| Low | 103.52 on 06/28/24 | 39.35 on 07/05/24 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 1,011.67 on 07/03/24 |
| High | 137.18 on 08/20/24 | 51.19 on 07/29/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 1,211.20 on 08/27/24 |
| 6-Month | |||||
| %Chg | +1.02% since 03/19/24 | -4.86% since 03/19/24 | +24.34% since 03/19/24 | +14.63% since 03/19/24 | +19.50% since 03/19/24 |
| Low | 100.08 on 05/30/24 | 39.35 on 07/05/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 875.22 on 04/26/24 |
| High | 144.19 on 03/21/24 | 54.47 on 03/28/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 1,211.20 on 08/27/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 20,863,522 | 100,827,960 | 178,589,936 | 104,514,608 | 125,480,912 |
| Shares Outstanding, K | 159,300 | 2,027,100 | 536,435 | 1,245,853 | 110,186 |
| Annual Sales | 4,504,000,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | -1,161,000,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 1,112,000,000 | 12,201,000,000 | 8,388,000,000 | 6,954,000,000 | 3,547,100,000 |
| Last Quarter Net Income | -1,988,000,000 | 1,680,000,000 | 746,000,000 | 1,614,000,000 | 1,432,300,000 |
| 60-Month Beta | 1.15 | 0.46 | 0.61 | 0.18 | 0.12 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.36 on 08/06/24 | 2.07 on 07/26/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | 11.56 on 08/01/24 |
| Latest Earnings Date | 08/06/24 | 10/31/24 | 10/29/24 | 11/05/24 | 11/07/24 |
| Most Recent Dividend | N/A | 0.600 on 07/05/24 | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 10/04/24 | 08/16/24 | 09/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 141.53 | 36.12 | 17.89 | 17.67 | 29.85 |